Emerging Lung Cancer Therapeutic Targets Based on the Pathogenesis of Bone Metastases
Lung cancer is the second most common cancer and the leading cause of cancer related mortality in both men and women. Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined. It is widely accepted that tumor metastasis is a formidable barrier to effective treat...
Main Authors: | Moses O. Oyewumi, Adnan Alazizi, Daniel Wehrung, Rami Manochakian, Fayez F. Safadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | International Journal of Cell Biology |
Online Access: | http://dx.doi.org/10.1155/2014/236246 |
Similar Items
-
Targeted Treatments of Bone Metastases in Patients with Lung Cancer
by: Vera eHirsh
Published: (2014-06-01) -
Emerging therapeutic agents for advanced non-small cell lung cancer
by: Ruqin Chen, et al.
Published: (2020-05-01) -
Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
by: Annie Schmid-Alliana, et al.
Published: (2018-01-01) -
Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers
by: Aaron C. Tan, et al.
Published: (2020-02-01) -
Targeted therapy in advanced non-small cell lung cancer: current advances and future trends
by: Umair Majeed, et al.
Published: (2021-07-01)